Shuanghuanglian injection downregulates nuclear factor-kappa B expression in mice with viral encephalitis

A mouse model of viral encephalitis was induced by intracranial injection of a Coxsackie virus B3 suspension. Quantitative real-time reverse transcription-PCR and western blot assay were applied to detect mRNA and protein expression of intelectin-2 and nuclear factor-kappa B in the viral encephaliti...

Full description

Saved in:
Bibliographic Details
Published inNeural regeneration research Vol. 7; no. 33; pp. 2592 - 2599
Main Authors Gu, Naibing, Tian, Ye, Di, Zhengli, Han, Caiping, Lei, Hui, Zhang, Gejuan
Format Journal Article
LanguageEnglish
Published India Medknow Publications & Media Pvt. Ltd 25.11.2012
Department of Neurology,Xi'an Center Hospital,Xi'an 710003,Shaanxi Province,China
Medknow Publications & Media Pvt Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A mouse model of viral encephalitis was induced by intracranial injection of a Coxsackie virus B3 suspension. Quantitative real-time reverse transcription-PCR and western blot assay were applied to detect mRNA and protein expression of intelectin-2 and nuclear factor-kappa B in the viral encephalitis and control groups. Nuclear factor-kappa B and intelectin-2 mRNA and protein expression were significantly increased in mice with viral encephalitis. After intraperitoneal injection of Shuanghuanglian at a dose of 1.5 mg/kg for 5 successive days, intelectin-2 and nuclear factor-kappa B protein and mRNA expression were significantly decreased. To elucidate the relationship between intelectin-2 and nuclear factor-kappa B, mice with viral encephalitis were administered an intracerebral injection of 107 pfu recombinant lentivirus expressing intelectin shRNA. Both protein and mRNA levels of intelectin and nuclear factor-kappa B in brain tissue of mice were significantly decreased. Experimental findings suggest that Shuanghuanglian injection may downregulate nuclear factor-kappa B production via suppression of intelectin production, thus inhibiting inflammation associated with viral encephalitis.
Bibliography:intelectin nuclear factor-kappa B viral encephalitis short hairpin RNA Shuanghuanglian injection mice lentivirus nervous system disease traditional Chinese medicine neural regeneration
Naibing Gu, Ye Tian, Zhengli Di, Caiping Han, Hui Lei, Gejuan Zhang (Department of Neurology, Xi’an Center Hospital, Xi’an 710003, Shaanxi Province, China )
A mouse model of viral encephalitis was induced by intracranial injection of a Coxsackie virus B3 suspension. Quantitative real-time reverse transcription-PCR and western blot assay were applied to detect mRNA and protein expression of intelectin-2 and nuclear factor-kappa B in the viral encephalitis and control groups. Nuclear factor-kappa B and intelectin-2 mRNA and protein expression were significantly increased in mice with viral encephalitis. After intraperitoneal injection of Shuanghuanglian at a dose of 1.5 mg/kg for 5 successive days, intelectin-2 and nuclear factor-kappa B protein and mRNA expression were significantly decreased. To elucidate the relationship between intelectin-2 and nuclear factor-kappa B, mice with viral encephalitis were administered an intracerebral injection of 107 pfu recombinant lentivirus expressing intelectin shRNA. Both protein and mRNA levels of intelectin and nuclear factor-kappa B in brain tissue of mice were significantly decreased. Experimental findings suggest that Shuanghuanglian injection may downregulate nuclear factor-kappa B production via suppression of intelectin production, thus inhibiting inflammation associated with viral encephalitis.
11-5422/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: This study was designed and performed by Naibing Gu, and completed with the technical support of Gejuan Zhang and Hui Lei. The data were analyzed by Ye Tian. The manuscript was written by Zhengli Di, and revised by Caiping Han.
Naibing Gu, Master, Attending physician, Department of Neurology, Xi’an Center Hospital, Xi’an 710003, Shaanxi Province, China
Author statements: The manuscript is original, has not been submitted to or is not under consideration by another publication, has not been previously published in any language or any form, including electronic, and contains no disclosure of confidential information or authorship/patent application disputations.
ISSN:1673-5374
1876-7958
DOI:10.3969/j.issn.1673-5374.2012.33.004